ASRS 2024: Healio’s top videos so far
Click Here to Manage Email Alerts
Healio’s top video perspectives from the American Society of Retina Specialists meeting highlight faricimab in diabetic macular edema as well as an axitinib implant for wet age-related macular degeneration.
Check out these videos and more below.
VIDEO: Extension study shows long-term efficacy, safety of faricimab in DME
Arshad M. Khanani, MD, MA, FASRS, discusses the just-released 4-year efficacy and safety outcomes of faricimab in diabetic macular edema. Watch here.
VIDEO: Axitinib implant addresses sustainability in wet AMD
Pravin U. Dugel, MD, of Ocular Therapeutix discusses the phase 3 program for Axpaxli, an axitinib implant for wet age-related macular degeneration. Watch here.
VIDEO: Port delivery system maintains visual, anatomic improvements in DME at 2 years
Carl C. Awh, MD, FASRS, of Tennessee Retina discusses the phase 3 Pagoda trial investigating the port delivery system with ranibizumab for diabetic macular edema. Watch here.
VIDEO: Good phase 2 results reported for gene therapy in wet AMD at 26 weeks
Laurent Fischer, MD, of Adverum Biotechnologies discusses 26-week results from the phase 2 LUNA study investigating Ixo-vec for neovascular age-related macular degeneration. Watch here.
VIDEO: Triamcinolone acetonide an option in those with uveitic macular edema, IOP issues
Danny Mammo, MD, of Cole Eye Institute discusses the real-world effect of triamcinolone acetonide on IOP in patients with uveitic macular edema. Watch here.
Collapse
Healio Coverage
Click Here to Manage Email Alerts